Navigation Links
Immtech Reports Fiscal Third Quarter 2008 Results
Date:2/11/2008

NEW YORK, Feb. 11 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (the "Company") (Amex: IMM) today announced results for its fiscal third quarter ended December 31, 2007.

For the three months ended December 31, 2007, revenues were $1,835,000, as compared to $546,000 for the three months ended December 31, 2006. The increase was primarily attributable to revenues relating to a licensing agreement and research agreement. Loss from operations for the three months ended December 31, 2007 was $5,305,000, as compared to a loss from operations of $3,946,000 for the three months ended December 31, 2006. The increase was primarily due to an increase in clinical trial costs. Net loss attributable to common stockholders for the three months ended December 31, 2007 was $5,336,000, or $0.34 per share, compared to a loss of $3,966,000, or $0.28 per share, in the previous year.

At December 31, 2007, unrestricted cash and cash equivalents were $9,444,000 as compared to $12,462,000 at March 31, 2007. For the same periods, restricted funds on deposit were $4,962,000 and $3,119,000, respectively.

The Company reported today that it is studying clinical trial data collected in all prior and ongoing clinical trials of pafuramidine in order to address the clinical hold. The clinical hold was made in response to abnormal liver findings in Phase I safety study subjects, as reported in a Company press release dated December 26, 2007.

Information to access a recording of the conference call to be held on February 11, 2008 at 4.30pm will be available starting on February 12th from the Immtech Pharmaceuticals web site (http://www.immtechpharma.com).

About Immtech Pharm
'/>"/>

SOURCE Immtech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Immtech Investor Conference Call Scheduled for February 11, 2008
2. Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine
3. Immtech to Present at The Bank of Montreal Healthcare Conference
4. Phlo Affiliate Reports Progress in New York City Metropolitan Area Roll-Out
5. Cryo-Cell International, Inc. Reports Results for Fiscal 2007
6. Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31, 2007
7. Bunge Reports Fourth Quarter Net Income of $245 Million
8. Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months
9. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
10. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
11. Recent Research Reports and Near-Term Corporate Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... / Rootstown, OH (PRWEB) January 22, 2015 ... platform, announced today that it has received AOAC-PTM Certifications for ... O1O3, O111, O121, and O145; collectively referred to as STEC ... O157, at 1 colony forming unit (cfu) per 325 g ...
(Date:1/22/2015)... January 22, 2015 Selexis SA, a ... Research Cell Banks (RCBs) used for drug discovery to ... Banks will include Next-Generation Sequencing (NGS) data ... de-risks biologic manufacturing by ensuring the integrity of the ...
(Date:1/22/2015)... 2015   GenoSpace , a precision medicine software company that ... broad use of genomic, imaging and other biomedical data in ... Michelle Munson , CEO of Aspera, an IBM Company, to ... http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased to ...
(Date:12/24/2014)... Dec. 24, 2014  Vermillion, Inc. (Nasdaq:   VRML), ... announced today that the Company closed its previously ... Management, Jack W. Schuler , Birchview Fund ... $10.5 million, before offering expenses.  The proceeds will ...
Breaking Biology Technology:Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2GenoSpace Expands Board with Appointment of Michelle Munson 2Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3
... Nov. 4 Uroplasty, Inc. (Amex:,UPI) announced today that ... Healthcare Conference on Monday, November 10, 2008 at the ... President and Chief Executive,Officer and Medi Jiwani, Vice President ... and historical financial,performance at 4:55 p.m. Eastern Time., ...
... Gene Amplification technology is one of the rapidly growing markets in ... Amplification technologies is projected to reach $2.2 billion. Major factors that ... associated with the existing and emerging technologies. , ... ...
... 2008) When Albrecht Durer and other Renaissance artists ... fine grooves and transferred the images to paper with ... later the same technique would uncover the secrets of ... Technology researchers have borrowed a technique from such "intaglio" ...
Cached Biology Technology:Uroplasty to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York 2World Gene Amplification Technologies Market to Reach $2.2 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 2World Gene Amplification Technologies Market to Reach $2.2 Billion by 2015, According to New Report by Global Industry Analysts, Inc. 3Protein-printing technique gives snapshots of immune system defense 2Protein-printing technique gives snapshots of immune system defense 3
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the first ... post-password and Internet of Things era, today announced the ... venture round was led by Metamorphic Ventures with participation ... Partners, VegasTechFund, and others.  LaunchKey has raised $4 million ...
(Date:12/17/2014)... SM announced today its completion of a Good ... current U.S. Food and Drug Administration (FDA) regulations. This ... smart phone application trials utilizing the highest principles for ... determined to improve global healthcare access, quality, and delivery ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is fundamentally transforming the ... at international borders. Over the past decade, ePassports, biometric ... to self process through border control via eGates and ... of airports, seaports, and land borders across the globe. ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... of British Columbia researchers have discovered the genetic machinery ... Army knife of the digestive tract helping us ... cell walls of fruits and vegetables. The findings ... the vast microbial community living in the human gut, ...
... be an option for the 40 million people worldwide who ... 65% of those with visual impairment and 82% of those ... In a special issue of Investigative Ophthalmology & Visual ... world address "the aging eye" to focus attention on unmet ...
... University of Nebraska-Lincoln, while using a camera-equipped robot to ... discovered a new species of small sea anemones that ... frigid water like flowers from a ceiling. ... an amazing find," said Marymegan Daly, a specialist in ...
Cached Biology News:Researchers collaborate to reduce effects of the aging eye 2New sea anemone species discovered in Antarctica 2New sea anemone species discovered in Antarctica 3New sea anemone species discovered in Antarctica 4
Human VASA Biotinylated Affinity Purified PAb...
Recombinant Mouse Matrilin-4, CF Protein Family: Extracellular Matrix Molecules, Chondrogenesis Markers...
An instrument that delivers an accurate and uniform amount of light energy to cells to photoactivate csiRNA products....
Use the DUALmembrane kit 3 to carry out DUALmembrane interaction analysis and cDNA library screening to characterize interactions between integral membrane proteins and to identify novel interaction ...
Biology Products: